Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
KR
KORU Medical Systems, Inc. Common Stock (DE)
KRMD
Volume
144.67K
Next Earnings
November 11th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
KR
KRMD
KR
KORU Medical Systems, Inc. Common Stock (DE)
KRMD
News
·
Reasons to Retain Doximity Stock in Your Portfolio for Now
Mkt Cap
$139.9M
Volume
144.67K
Next Earnings
November 11th
Chart
Financials
Earnings
News
About
Insider
Filings
Reasons to Retain Doximity Stock in Your Portfolio for Now
Doximity (DOCS) is experiencing strong clinical AI adoption with active workflow prescribers up 30% year-over-year and AI Scribe users growing 10-fold, validating its AI capabilities through independent studies. However, the company faces headwinds from modest overall revenue growth (7% YoY), declining gross margins (88% from 91%) due to elevated AI infrastructure costs, and a constrained pharma advertising market. While AI is opening new revenue opportunities, investors await evidence that AI monetization can materially accelerate consolidated growth.
Zacks Investment Research · Oct 5, 2026
Cirtec Medical Announces Appointment of New Chief Executive Officer
Cirtec Medical has appointed Shar Matin as its new CEO, effective September 2, 2025. Matin brings over 25 years of global leadership experience in medical technology, previously serving as CEO of Cordis and holding executive roles at multiple medical technology companies.
GlobeNewswire Inc. · Aug 28, 2025
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 50% and 9.45%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · May 1, 2024
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) delivered earnings and revenue surprises of 13.64% and 6.41%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Mar 12, 2024
KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion
One key aspect of the collaboration of KORU Medical (KRMD) with a pharmaceutical manufacturer is the exploration of new therapeutic settings.
Zacks Investment Research · Mar 12, 2024
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
Silk Road Medical (SILK) delivered earnings and revenue surprises of 17.50% and 11.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Feb 28, 2024
Breaking The Hospital Chain: Analyst On How KORU's Self-Administered Therapies Promise 20% CAGR Through 2026
B. Riley has initiated coverage of KORU Medical Systems Inc (NASDAQ: KRMD) with a Buy rating and a price target of $4.50. The analyst Neil Chatterji notes that KORU Medical's innovative Freedom Infusion System represents a significant advancement in medical treatment by delivering drugs subcutaneously (under the skin). The system primarily targets the growing subcutaneous immunoglobulin (SCIg) market, valued at approximately $500 million, catering to patients with immunodeficiency and other related conditions. Moreover, it is poised to transform into a versatile therapy delivery platform, ...Full story available on Benzinga.com
Benzinga · Sep 7, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
Upgrades For Tri Pointe Homes Inc (NYSE:TPH), Oppenheimer upgraded the previous rating of Perform to Outperform. For the second quarter, Tri Pointe Homes had an EPS of $0.60, compared to year-ago quarter EPS of $1.33. At the moment, the stock has a 52-week-high of $34.04 and a 52-week-low of $14.63. Tri Pointe Homes closed at $29.60 at the end of the last trading period. Truist Securities upgraded the previous rating for Vail Resorts Inc (NYSE:MTN) from Hold to Buy. In the third quarter, Vail Resorts showed an EPS of $8.18, compared to $9.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $268.24 and a 52-week-low of $202.00. Vail Resorts closed at $243.05 at the end of the last trading period. According to Wells Fargo, the prior rating for McDonald's Corp (NYSE:MCD) was changed from Equal-Weight to Overweight. For the second quarter, McDonald's had an EPS of $3.17, compared to year-ago quarter EPS of $2.55. The stock has a 52-week-high of $299.35 and a 52-week-low of $230.62. At the end of the last trading period, McDonald's closed at $275.44. According to Goldman Sachs, the prior rating for Owens-Corning Inc (NYSE:OC) was changed from Sell to Neutral. Owens-Corning earned $4.22 in the second quarter, compared to $3.83 in the year-ago quarter. At the moment, the stock has a 52-week-high of $147.00 and a 52-week-low of $74.25. Owens-Corning closed at $142.50 at the end of the last trading period. See all analyst ratings upgrades. Downgrades According to Alembic Global, the prior rating for AeroVironment Inc (NASDAQ:AVAV) was changed from Overweight to Neutral. For the first quarter, AeroVironment had an EPS of $1.00, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $124.33 and a 52-week-low of $74.91. At the end of the last trading period, AeroVironment closed at $115.05. According to Noble Capital Markets, the prior rating for Bassett Furniture Industries Inc (NASDAQ:BSET) was changed from Outperform to Market Perform. In the second quarter, Bassett Furniture Indus showed an EPS of $0.24, compared to $0.81 from the year-ago quarter. At the moment, the stock has a 52-week-high of $19.99 and a 52-week-low of $13.30. Bassett Furniture Indus closed at $15.20 at the end of the last trading period. For Akoustis Technologies Inc (NASDAQ:AKTS), B. Riley Securities downgraded the previous rating of Buy to Neutral. Akoustis Technologies earned $0.21 in the fourth quarter, compared to $0.26 in the year-ago quarter. The current stock performance of Akoustis Technologies shows a 52-week-high of $4.96 and a 52-week-low of $1.07. Moreover, at the end of the last trading period, the closing price was at $1.16. Fox Advisors downgraded the previous rating for ChargePoint Holdings Inc (NYSE:CHPT) from Overweight to Equal-Weight. ChargePoint Hldgs earned $0.24 in the second quarter, compared to $0.18 in the year-ago quarter. The stock has a 52-week-high of $19.92 and a 52-week-low of $6.65. At the end of the last trading period, ChargePoint Hldgs closed at $7.06. According to Evercore ISI Group, the prior rating for Verint Systems Inc (NASDAQ:VRNT) was changed from Outperform to In-Line. Verint Systems earned $0.48 in the second quarter, compared to $0.56 in the year-ago quarter. The current stock performance of Verint Systems shows a 52-week-high of $46.89 and a 52-week-low of $30.60. Moreover, at the end of the last trading period, the closing price was at $30.87. For Dave & Buster's Entertainment Inc (NASDAQ:PLAY), Raymond James downgraded the previous rating of Strong Buy to Outperform. Dave & Buster's Enter earned $0.94 in the second quarter, compared to $0.85 in the year-ago quarter. The current stock performance of Dave & Buster's Enter shows a 52-week-high of $47.29 and a 52-week-low of $30.38. Moreover, at the end of the last trading period, the closing price was at $37.40. According to Northcoast Research, the prior rating for NCR Corp (NYSE:NCR) was changed from Buy to Neutral. In the second quarter, NCR showed an EPS of $0.94, compared to $0.71 from the year-ago quarter. The stock has a 52-week-high of $32.72 and a 52-week-low of $18.06. At the end of the last trading period, NCR closed at $28.83. According to Wells Fargo, the prior rating for Greenbrier Companies Inc (NYSE:GBX) was changed from Overweight to Equal-Weight. In the third quarter, Greenbrier Companies showed an EPS of $1.02, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $48.21 and a 52-week-low of $23.97. At the end of the last trading period, Greenbrier Companies closed at $41.64. For Verint Systems Inc (NASDAQ:VRNT), Oppenheimer downgraded the previous rating of Outperform to Perform. Verint Systems earned $0.48 in the second quarter, compared to $0.56 in the year-ago quarter. The current stock performance of Verint Systems shows a 52-week-high of $46.89 and a 52-week-low of $30.60. Moreover, at the end of the last trading period, the closing price was at $30.87. According to UBS, the prior rating for Tronox Holdings PLC (NYSE:TROX) was changed from Buy to Neutral. In the second quarter, Tronox Holdings showed an EPS of $0.16, compared to $0.84 from the year-ago quarter. The stock has a 52-week-high of $17.61 and a 52-week-low of $10.58. At the end of the last trading period, Tronox Holdings closed at $13.90. According to Baird, the prior rating for Torrid Holdings Inc (NYSE:CURV) was changed from Outperform to Neutral. For the second quarter, Torrid Holdings had an EPS of $0.06, compared to year-ago quarter EPS of $0.22. At the moment, the stock has a 52-week-high of $6.90 and a 52-week-low of $2.04. Torrid Holdings closed at $2.20 at the end of the last trading period. According to Barclays, the prior rating for Dell Technologies Inc (NYSE:DELL) was changed from Equal-Weight to Underweight. In the second quarter, Dell Technologies showed an EPS of $1.74, compared to $1.68 from the year-ago quarter. At the moment, the stock has a 52-week-high of $70.48 and a 52-week-low of $32.90. Dell Technologies closed at $70.47 at the end of the last trading period. According to Barclays, the prior rating for Seagate Technology Holdings PLC (NASDAQ:STX) was changed from Overweight to Equal-Weight. For the fourth quarter, Seagate Tech Hldgs had an EPS of $0.18, compared to year-ago quarter EPS of $1.59. The current stock performance of Seagate Tech Hldgs shows a 52-week-high of $74.51 and a 52-week-low of $47.47. Moreover, at the end of the last trading period, the closing price was at $71.23. For Polestar Automotive Holding UK PLC (NASDAQ:PSNY), Barclays downgraded the previous rating of Equal-Weight to Underweight. For the second quarter, Polestar Automotive had an EPS of $0.14, compared to year-ago quarter EPS of $0.12. At the moment, the stock has a 52-week-high of $8.25 and a 52-week-low of $3.11. Polestar Automotive closed at $3.13 at the end of the last trading period. According to B. Riley Securities, the prior rating for Crocs Inc (NASDAQ:CROX) was changed from Buy to Neutral. For the second quarter, Crocs had an EPS of $3.59, compared to year-ago quarter EPS of $3.24. The current stock performance of Crocs shows a 52-week-high of $151.32 and a 52-week-low of $65.20. Moreover, at the end of the last trading period, the closing price was at $96.36. ...Full story available on Benzinga.com
Benzinga · Sep 7, 2023
KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates
KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 0% and 0.09%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Aug 9, 2023
Masimo (MASI) Q2 Earnings Miss Estimates
Masimo (MASI) delivered earnings and revenue surprises of -27.91% and 0.18%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Aug 8, 2023
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
KR
KRMD
KORU Medical Systems, Inc. Common Stock (DE)
Buy
Sell
Market
Limit
Soon
KRMD
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any KRMD yet.
Related Tickers
Earnings